Nucor earnings beat by $0.08, revenue fell short of estimates
NORTHBROOK, Ill. - Stepan Company (NYSE:SCL), a major chemical manufacturer, declared a quarterly cash dividend of $0.385 per share on its common stock today. The dividend is scheduled to be paid on June 13, 2025, to shareholders of record as of May 30, 2025. This marks a slight increase from the previous quarter’s dividend, with a current yield of 3.2%. According to InvestingPro data, the company has maintained dividend payments for 54 consecutive years, though the stock has faced challenges with a 33.2% decline over the past six months.
Stepan Company, headquartered in Northbrook, Illinois, specializes in the production of specialty and intermediate chemicals. The company is recognized as a leading merchant producer of surfactants, essential components in cleaning and disinfection products for consumer and industrial use, as well as in agricultural and oilfield applications. Additionally, Stepan is a prominent supplier of polyurethane polyols, which are used in the growing thermal insulation market, and in the CASE (Coatings, Adhesives, Sealants, and Elastomers) industries. With annual revenues of $2.18 billion and an EBITDA of $183.29 million, InvestingPro analysis suggests the stock is currently undervalued, trading at a P/E ratio of 26.33 with strong potential for earnings growth.
With a network of modern production facilities spread across the Americas, Europe, and Asia, Stepan Company ensures a global reach for its products and services. The company’s common stock is publicly traded on the New York Stock Exchange under the ticker symbol SCL.
Investors and those interested in the company’s sustainability initiatives can find more information on Stepan’s official website, including details about its sustainability program.
The information in this announcement includes forward-looking statements, which are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those projected. These statements are not guarantees of future performance, and investors are cautioned not to place undue reliance on them.
This news article is based on a press release statement from Stepan Company. For a comprehensive analysis of Stepan’s financial health, valuation metrics, and additional ProTips, investors can access the detailed Pro Research Report available on InvestingPro, which provides expert insights on over 1,400 US stocks.
In other recent news, Stepan Company reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of $0.12, which fell short of the forecasted $0.45. The company’s revenue for the quarter was $525.6 million, slightly below the expected $533.41 million. Despite these misses, the company expressed optimism about future growth, particularly in its agricultural and oilfield markets, and is making strategic investments in new facilities and products. The full-year adjusted EBITDA increased by 4% to $187 million, even though the adjusted EBITDA for the fourth quarter decreased by 7% year-over-year to $35 million. Stepan Company also announced that Edward J. Wehmer will retire from its Board of Directors in April 2025, after serving since 2003. The Board will reduce its size from eight to seven directors, with Randall S. Dearth taking over as Lead Independent Director. The company continues to expand its customer base, adding over 1,700 new clients in 2024, and is preparing to start operations at its new oxalation production facility in Pasadena, Texas, in early 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.